{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T22:24:54Z","timestamp":1774304694942,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T00:00:00Z","timestamp":1741478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007459","name":"Multiple Sclerosis International Federation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004270","name":"Kungliga Tekniska H\u00f6gskolan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jns.2025.123461","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T03:24:31Z","timestamp":1741577071000},"page":"123461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Association of IL2RA and multiple sclerosis risk: A case control, systematic review, and meta-analysis study"],"prefix":"10.1016","volume":"472","author":[{"given":"Fatemeh","family":"Rangani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahid","family":"Rakhshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Kadkhoda Mezerji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asieh","family":"Alikhah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reyhaneh","family":"Dehghanzad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babak","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amirhossein","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Nikravesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Pahlevan Kakhki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jns.2025.123461_bb0005","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028936","article-title":"Multiple sclerosis pathology","volume":"8","author":"Lassmann","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"14","key":"10.1016\/j.jns.2025.123461_bb0010","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.jns.2025.123461_bb0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.msard.2017.09.005","article-title":"CD25 gene polymorphism and multiple sclerosis","volume":"18","author":"Alsahebfosoul","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.jns.2025.123461_bb0020","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.immuni.2017.03.013","article-title":"Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors","volume":"46","author":"Arce Vargas","year":"2017","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.jns.2025.123461_bb0025","doi-asserted-by":"crossref","first-page":"40623","DOI":"10.1038\/srep40623","article-title":"Multi-cellular natural killer (NK) cell clusters enhance NK cell activation through localizing IL-2 within the cluster","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"issue":"9\u201310","key":"10.1016\/j.jns.2025.123461_bb0030","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.imbio.2008.07.026","article-title":"CD25 as an immune regulatory molecule expressed on myeloid dendritic cells","volume":"213","author":"Driesen","year":"2008","journal-title":"Immunobiology"},{"issue":"4","key":"10.1016\/j.jns.2025.123461_bb0035","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2567.2006.02331.x","article-title":"Phenotypic and functional characterization of human CD25+ B cells","volume":"117","author":"Brisslert","year":"2006","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.jns.2025.123461_bb0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-065X.2011.01004.x","article-title":"T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells","volume":"241","author":"Cheng","year":"2011","journal-title":"Immunol. Rev."},{"issue":"11","key":"10.1016\/j.jns.2025.123461_bb0045","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/ni.3540","article-title":"An essential role for the IL-2 receptor in T(reg) cell function","volume":"17","author":"Chinen","year":"2016","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.jns.2025.123461_bb0050","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/1074-7613(95)90180-9","article-title":"Interleukin-2 receptor \u03b1 chain regulates the size and content of the peripheral lymphoid compartment","volume":"3","author":"Willerford","year":"1995","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.jns.2025.123461_bb0055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/gene.2010.28","article-title":"IL12A, MPHOSPH9\/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci","volume":"11","author":"Consortium","year":"2010","journal-title":"Genes Immun."},{"issue":"9","key":"10.1016\/j.jns.2025.123461_bb0060","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ng2102","article-title":"Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes","volume":"39","author":"Lowe","year":"2007","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.jns.2025.123461_bb0065","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa073493","article-title":"Risk alleles for multiple sclerosis identified by a genomewide study","volume":"357","author":"Consortium","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.jns.2025.123461_bb0070","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ng2068","article-title":"Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes","volume":"39","author":"Todd","year":"2007","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.jns.2025.123461_bb0075","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.4049\/jimmunol.182.3.1541","article-title":"Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses","volume":"182","author":"Maier","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jns.2025.123461_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004137","article-title":"IL2RA\/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D)","volume":"4","author":"Alcina","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jns.2025.123461_bb0085","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/art.24187","article-title":"Association of the IL2RA\/CD25 gene with juvenile idiopathic arthritis","volume":"60","author":"Hinks","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.jns.2025.123461_bb0090","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-3083.2011.02608.x","article-title":"A variant of the Il2ra\/Cd25 gene predisposing to Graves\u2019 disease is associated with increased levels of soluble Interleukin-2 receptor","volume":"74","author":"Chistiakov","year":"2011","journal-title":"Scand. J. Immunol."},{"issue":"5","key":"10.1016\/j.jns.2025.123461_bb0095","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1177\/147323001103900505","article-title":"Interleukin 2 receptor \u03b1 gene polymorphism and risk of multiple sclerosis: a meta-analysis","volume":"39","author":"Wang","year":"2011","journal-title":"J. Int. Med. Res."},{"issue":"1","key":"10.1016\/j.jns.2025.123461_bb0100","first-page":"26","article-title":"Association between single nucleotide polymorphisms rs12722489 and multiple sclerosis in Iranian patients with multiple sclerosis","volume":"19","author":"Ahmadi","year":"2020","journal-title":"Curr. J. Neurol."},{"key":"10.1016\/j.jns.2025.123461_bb0105","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/978-1-60761-411-1_30","article-title":"Meta-analysis: drawing conclusions when study results vary","volume":"594","author":"Rosenthal","year":"2010","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.jns.2025.123461_bb0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jns.2025.123461_bb0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jns.2015.02.005","article-title":"Expression of suppressor of cytokine signaling 1 (SOCS1) gene dramatically increases in relapsing\u2013remitting multiple sclerosis","volume":"350","author":"Pahlevan Kakhki","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2025.123461_bb0120","first-page":"372","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"10.1016\/j.jns.2025.123461_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int. J. Surg."},{"issue":"10","key":"10.1016\/j.jns.2025.123461_bb0130","article-title":"Meta-analysis in clinical trials","volume":"177","author":"DerSimonian","year":"2025","journal-title":"Control. Clin. Trials"},{"issue":"4","key":"10.1016\/j.jns.2025.123461_bb0135","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959"},{"issue":"3","key":"10.1016\/j.jns.2025.123461_bb0140","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/icvts\/ivy163","article-title":"Statistical primer: heterogeneity, random-or fixed-effects model analyses?","volume":"27","author":"Barili","year":"2018","journal-title":"Interact. Cardiovasc. Thorac. Surg."},{"key":"10.1016\/j.jns.2025.123461_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577346","article-title":"The association of genetic variants IL2RA rs2104286, IFI30 rs11554159 and IKZF3 rs12946510 with multiple sclerosis onset and severity in patients from Serbia","volume":"347","author":"Stefanovi\u0107","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2025.123461_bb0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2015.03.015","article-title":"GWAS-identified multiple sclerosis risk loci involved in immune response: validation in Russians","volume":"282","author":"Bashinskaya","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2025.123461_bb0155","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10048-014-0403-3","article-title":"Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression","volume":"15","author":"Traboulsee","year":"2014","journal-title":"Neurogenetics"},{"issue":"12","key":"10.1016\/j.jns.2025.123461_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083811","article-title":"Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25hi T cells of type 1 diabetic and multiple sclerosis patients","volume":"8","author":"Cerosaletti","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.jns.2025.123461_bb0165","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ejhg.2010.15","article-title":"Polymorphisms in the IL2, IL2RA and IL2RB genes in multiple sclerosis risk","volume":"18","author":"Cavanillas","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.jns.2025.123461_bb0170","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaut.2009.01.002","article-title":"Variation in the IL7RA and IL2RA genes in German multiple sclerosis patients","volume":"32","author":"Akkad","year":"2009","journal-title":"J. Autoimmun."},{"issue":"7","key":"10.1016\/j.jns.2025.123461_bb0175","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/gene.2008.59","article-title":"Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians","volume":"9","author":"Rubio","year":"2008","journal-title":"Genes Immun."},{"issue":"1\u20132","key":"10.1016\/j.jns.2025.123461_bb0180","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jneuroim.2013.04.022","article-title":"The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort","volume":"261","author":"Qiu","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"6460","key":"10.1016\/j.jns.2025.123461_bb0185","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility","volume":"365","author":"Consortium","year":"2019","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jns.2025.123461_bb0190","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/gene.2008.14","article-title":"IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations","volume":"9","author":"Weber","year":"2008","journal-title":"Genes Immun."},{"issue":"4","key":"10.1016\/j.jns.2025.123461_bb0195","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/gene.2009.81","article-title":"Multiple sclerosis susceptibility alleles in African Americans","volume":"11","author":"Johnson","year":"2010","journal-title":"Genes Immun."},{"issue":"5","key":"10.1016\/j.jns.2025.123461_bb0200","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1177\/1352458510394703","article-title":"Association of IL2RA p olymorphisms with susceptibility to multiple sclerosis is not explained by missense mutations in IL2RA","volume":"17","author":"Matiello","year":"2011","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.jns.2025.123461_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.mgene.2020.100750","article-title":"Association between interleukin 2 receptor A gene polymorphisms (rs2104286 and rs12722489) with susceptibility to multiple sclerosis in Iranian population","volume":"25","author":"Pourakbari","year":"2020","journal-title":"Meta Gene"},{"issue":"12","key":"10.1016\/j.jns.2025.123461_bb0210","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1080\/01616412.2018.1517110","article-title":"A genetic link between CXCR5 and IL2RA gene polymorphisms and susceptibility to multiple sclerosis","volume":"40","author":"Xia","year":"2018","journal-title":"Neurol. Res."},{"issue":"4","key":"10.1016\/j.jns.2025.123461_bb0215","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4103\/0972-2327.192384","article-title":"CD6 gene polymorphism rs17824933 is associated with multiple sclerosis in Indian population","volume":"19","author":"D\u2019Cunha","year":"2016","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jns.2025.123461_bb0220","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jns.2013.11.037","article-title":"Interleukin 2 receptor \u03b1 chain gene polymorphisms and risks of multiple sclerosis and neuromyelitis optica in southern Japanese","volume":"337","author":"Ainiding","year":"2014","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.jns.2025.123461_bb0225","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1017\/S0317167100015973","article-title":"IL2RA allele increases risk of neuromyelitis optica in Southern Han Chinese","volume":"40","author":"Dai","year":"2013","journal-title":"Can. J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jns.2025.123461_bb0230","first-page":"198","article-title":"Analysis of single nucleotide polymorphisms in HLA-DRA, IL2RA, and HMGB1 genes in multiple sclerosis","volume":"9","author":"Asouri","year":"2020","journal-title":"Rep. Biochem. Mol. Biol."},{"issue":"9","key":"10.1016\/j.jns.2025.123461_bb0235","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/acn3.50862","article-title":"Environmental and genetic risk factors for MS: an integrated review","volume":"6","author":"Waubant","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jns.2025.123461_bb0240","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.neulet.2017.05.050","article-title":"The expression of VDR mRNA but not NF-\u03baB surprisingly decreased after vitamin D treatment in multiple sclerosis patients","volume":"653","author":"Shirvani-Farsani","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"9","key":"10.1016\/j.jns.2025.123461_bb0245","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa073493","article-title":"Risk alleles for multiple sclerosis identified by a genomewide study","volume":"357","author":"Hafler","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jns.2025.123461_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172681","article-title":"The single nucleotide variant rs12722489 determines differential estrogen receptor binding and enhancer properties of an IL2RA intronic region","volume":"12","author":"Afanasyeva","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jns.2025.123461_bb0255","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/08820139.2018.1425699","article-title":"Meta-analysis of the association of IL2RA polymorphisms rs2104286 and rs12722489 with multiple sclerosis risk","volume":"47","author":"Wang","year":"2018","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.jns.2025.123461_bb0260","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00023210-200216060-00004","article-title":"Differentiation of multiple sclerosis subtypes: implications for treatment","volume":"16","author":"Bitsch","year":"2002","journal-title":"CNS Drugs"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25000784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25000784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:50:55Z","timestamp":1762210255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X25000784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":52,"alternative-id":["S0022510X25000784"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.123461","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of IL2RA and multiple sclerosis risk: A case control, systematic review, and meta-analysis study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.123461","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123461"}}